Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000845563 | SCV000208170 | benign | not provided | 2018-08-01 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26332594, 22763267, 19150014, 21310275, 12110947, 22765922, 20800588, 29032884, 31006259) |
Agnes Ginges Centre for Molecular Cardiology, |
RCV000172893 | SCV000223884 | likely benign | Hypertrophic cardiomyopathy 1 | 2015-03-18 | criteria provided, single submitter | research | The MYBPC3 Arg1138His variant has been previously reported in both the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/) at a frequency of 0.017 (72 of 4168 in the European Finnish population), and at a frequency of 0.002 in the European sub-population of the 1000 genomes project (http://www.1000genomes.org/). We observed this variant in a single proband with typical HCM, presented 27 years and has no clear family history of disease. No other variants were identified. The variant has been reported in the literature (Jääskeläinen P, et al., 2002; García-Castro M, et al., 2009; Golbus JR, et al., 2012). Jääskeläinen et al. (2002) sequenced MYBPC3 in a Finnish HCM population and normal cohort, and identified this Arg1138His variant in multiple families (3 unrelated probands and 5 normal control samples). The variant does not co-segregate with disease and homozygous individuals did not express the HCM phenotype. Another report from Garcia-Castro et al. (2009) identified the Arg1138His variant in a single proband amongst a Spanish HCM population, however this proband is described as having no family history of disease and a concentric pattern of hypertrophy (IVS and PW 19mm). Arginine (Arg) at position 1138 is conserved across distantly related species, however the computational tool specifically designed to predict the effects of missense variants in HCM genes (Jordan DM, et al., 2011), cannot predict the outcome of this MYBPC3 Arg1138His variant. Due to the allele frequency of > 0.001 in population databases, and literature evidence, we classify this variant as "likely benign". |
Invitae | RCV000629118 | SCV000750032 | benign | Hypertrophic cardiomyopathy | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000845563 | SCV000987692 | likely benign | not provided | criteria provided, single submitter | clinical testing | ||
Center for Advanced Laboratory Medicine, |
RCV000852647 | SCV000995352 | likely benign | Cardiomyopathy | 2017-12-06 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988535 | SCV001138287 | benign | Hypertrophic cardiomyopathy 4 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000852647 | SCV001353191 | benign | Cardiomyopathy | 2018-11-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453507 | SCV002612763 | benign | Cardiovascular phenotype | 2019-06-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000852647 | SCV004239380 | likely benign | Cardiomyopathy | 2023-01-13 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000154288 | SCV000203947 | uncertain significance | not specified | 2013-02-11 | no assertion criteria provided | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |
Blueprint Genetics | RCV000157320 | SCV000207055 | likely benign | Primary familial hypertrophic cardiomyopathy | 2014-03-25 | no assertion criteria provided | clinical testing | |
Blueprint Genetics | RCV000157321 | SCV000207056 | likely benign | Primary dilated cardiomyopathy | 2014-03-25 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000845563 | SCV001740288 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000845563 | SCV001931387 | likely benign | not provided | no assertion criteria provided | clinical testing |